AzTrials
AzTrials

Aerobic ExerciseNCT04042896

Effects of Exergame in Patients at High Cardiovascular Risk.

A study testing exergame and treadmill exercise in people with Aerobic Exercise and Cardiorespiratory Fitness, run by Kyoung Im Cho at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Exergaming is thought to have a similar effect on cardiovascular (CV) responses as aerobic fitness activities. The aim of this study was to compare the cardiovascular effects of exergaming and traditional treadmill exercises in patients with high CV risk. Read more about this study

Who is it for?
Ages 50 to 80 years, women only
What is being tested?
exergame and treadmill exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteSouth Korea
Study dates
1 Apr 2017to 31 Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Framingham CV disease 10-year risk score above 20%
  • post-menopausal women
  • no history of exercise

Who cannot join

  • resistant hypertension
  • liver disease
  • neurologic disorders
  • malignant disease
  • chronic obstructive pulmonary disease
  • valvular heart disease
  • musculoskeletal patients

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Kosin University Gospel Hospital

    Busan, 49267

Other trials in South Korea

About this study

Official title: Effects of Exergame vs. Traditional Aerobic Exercise in Patients at High Cardiovascular Risk

Background: Exergaming is thought to have a similar effect on cardiovascular (CV) responses as aerobic fitness activities. The aim of this study was to compare the cardiovascular effects of exergaming and traditional treadmill exercises in patients with high CV risk.

Methods: Sixty-four patients with high CV risk were randomized among exergame (EG: n = 22), treadmill (TM: n = 22), and control (n=20) groups. The EG group was engaged in the running-based exergame using Exer Heart and the TM group walked or jogged on a treadmill. Cardiorespiratory fitness (CRF), brachial artery flow-mediated dilation (FMD), endothelial progenitor cell numbers (EPCs), epicardial fat thickness (EFT), metabolic parameters and anthropometric parameters were measured in patients before and 3 months after the training.

Read the detailed description

Introduction Cardiovascular (CV) disease is a major cause of premature death and morbidity worldwide. It is widely known that age, sex, hypertension, dyslipidemia, diabetes, and smoking are the main risk factors which can cause CV disease[1]. Many other CV risk factors and their markers have been identified in recent studies. Among these, cardiorespiratory fitness (CRF) and endothelial dysfunction are strong predictors of the risk of developing CV disease[2, 3]. In addition, epicardial adipose tissue is a visceral fat which accumulates in the epicardium of the heart, and has recently been considered as a new index of CV risk[4, 5].

It is well established that regular exercise (physical activity) is effective in preventing and treating CV risk factors by improving health-related fitness[6]. Despite the health benefits of regular exercise, many patients with CV risk factors often do not participate in regular exercise for reasons including lack of time, motivation, or interest.

In recent years, a new exercise program called exergame has been developed as a result of the technical advancements in gaming and virtual reality programs. Exergames are interactive video games which provide the opportunity to increase physical activity by requiring movement of the entire body[7] and are proving to be an alternative exercise modality. In addition, exergames are used to fight pediatric obesity[8], improve senior physical performance[9], and facilitate poststroke motor rehabilitation[10]. However, only a few studies have examined the effects of exergaming on CV or chronic disease related risk factors. Furthermore, in order for exergames to progress as a rehabilitation program for the prevention and treatment of CV disease in the future, it is necessary to compare it to traditional aerobic exercises.

Therefore, the aim of this study was to compare the effects of exergame versus treadmill exercises on cardiorespiratory fitness (CRF), endothelial function, epicardial fat, cardiometabolic, and anthropometric parameters in patients with high CV risk.

Methods Participants and Study Design This single-center study was approved by the Institutional Review Board of Kosin University Gospel Hospital (Protocol no. KUGH 2016-06-029). Sixty-four female patients with a Framingham CV disease 10-year risk score above 20% were enrolled in this study[11, 12]. All participants voluntarily participated in the study and signed a consent form agreeing to the study process. In order to reduce the margin of error due to sex differences and physiological responses to the greatest degree possible, only post-menopausal women were recruited considering the hormonal changes which occur during menstruation. The inclusion criteria were post-menopausal women aged ≤80 years who did not have a history of participating in regular exercise within the past 3 months. The exclusion criteria were resistant hypertension, any systemic disease including significant liver disease, neurologic disorders, malignant disease, renal failure, chronic obstructive pulmonary disease, valvular heart disease, a positive treadmill test, a history of acute coronary syndrome, myocardial infarction or any revascularization procedure, or musculoskeletal patients for whom exercise was impossible. Patients were randomized to the exergame (EG: n=22), treadmill (TM: n=22), or control (n=20) groups.

All subjects were tested over a two-day period before and after 3 months of training. On the first visit, the subject's height, weight, waist circumference (WC), blood sampling, and blood pressure (BP) were obtained after 8 hours of fasting. On the second visit, brachial artery flow mediated dilatation (FMD), epicardial fat thickness (EFT) measured by echocardiography, and CRF tests were performed after 4 hours fasting. In addition, subjects were asked to refrain from excessive exercise, overeating, and caffeine consumption for 24 hours before all tests.

Cardiorespiratory Fitness CRF was assessed using a treadmill testing protocol[13]. The test was carried out on a programmable treadmill (GE CASE T2100; GE Medical Systems, Milwaukee, WI, USA) using a Ramp protocol until exhaustion in a temperature-controlled room (21-23°C). The cardiac rhythm was continuously monitored with a 12-lead electrocardiogram system. BP monitoring was carried out using an automated device (Suntech Tango; Suntech Medical, Morrisville, NC, USA). Ventilation (VE), oxygen uptake (VO2), and carbon dioxide output (VCO2) were measured using a computerized system (Cosmed K4b2, Cosmed Ltd., Rome, Italy). The termination of the test occurred when the subject's rated perceived exertion (RPE) was greater than 17, the respiratory exchange ratio was greater than 1.05, the oxygen intake had plateaued despite an increased workload, or the subject requested test termination. The highest recorded oxygen intake was defined as the VO2 peak of each person.

Flow-Mediated Dilation FMD was measured in the brachial artery according to current guidelines[14]. After the subject had relaxed sufficiently for 10 to 20 minutes in the supine position, the baseline value was measured. Two-dimensional ultrasonography (Vivid 7; General Electric, Horten, Norway) was performed using a 10-MHz linear-array transducer probe. After the baseline measurement, reactive hyperemia was induced by the inflation of a pneumatic cuff to 180-200 mmHg (50 mmHg higher than SBP) for five minutes on the forearm. For the peak diameter of the brachial artery, the diameter was recorded 40-60-seconds after sudden deflation of the cuff. The percent FMD induced by reactive hyperemia was expressed as the relative change from baseline (%FMD = 100 × [diameter after hyperemia-baseline diameter]/baseline diameter). At the peak of the R wave of the surface electrocardiogram, each diameter was measured three times during two heartbeats and the average values were used for the final analysis.

Epicardial Fat Thickness Epicardial adipose tissue was measured by assessing EFT through echocardiography[15]. Echocardiographic assessment of the EFT was defined as the echo-free space between the outer wall of the myocardium and the visceral layer of the pericardium. Standard 2-dimensional echocardiography was performed with the subject in the left lateral decubitus position using a 3.5 MHz transducer (Philips iE33, Philips Medical Systems, Bothell, WA, USA). The echocardiographic EFT test was conducted vertically from the free wall of the right ventricle at the end-systolic point in 3 heart cycles. One of the major problems with EFT measurements is the inconsistency of measurement locations. Therefore, in this study, the EFT value was recorded by considering the average of the parasternal long axis, parasternal short axis, and apical 4-chamber view. In addition, to minimize observational bias in a priori and post-hoc analyses, the researcher was blinded to the baseline value.

Exercise Training The EG group performed exercise using the Exer Heart device (D\&J Humancare, Seoul, South Korea), which consisted of a running/jumping board and a screen connected to the board (Figure 1). The exercise program "Alchemist's Treasure", a running-based exergame, moves the avatar according to the user's motions and was used for the exercise session. "Alchemist's Treasure" is a game in which the user listens to stimulating music, runs with the avatar, avoiding obstacles, and wins items using the front, back, left, and right sensors on the exercise board (Figure 2). The subject can control the speed of the avatar movement by adjusting the walking or running speed on the board. Furthermore, the Exer Heart game does not harm the joints, as the activities are performed on the exercise board's soft material.

The exergame cannot continuously maintain intensity by fixing the speed and inclination like a treadmill motion due to the characteristics of the program. On the other hand, the biggest advantage of the exergame is enjoyment. This study did not enforce exercise intensity in order to allow patients to enjoy the exergame. Thus, during the training period, the patients exercised at a self-selected pace for 40 minutes per day. Instead, we monitored individual exercise intensity by monitoring HR (Polar RS400sd; Madison Height, Michigan, USA) and recorded the resting, minimum, maximum, and average HR during the exergame training period. The resting HR of the patients was 79 ± 12 beats per minute (bpm), the minimum HR was 98 ± 26 bpm, the maximum HR was 153 ± 28 bpm, and the mean HR was 120 ±19. According to the guidelines of the American College of Sports Medicine (ACSM), the range of exercise intensity for exergaming is between 42% and 82% of HR reserve.

The TM group consisted of 40 minutes of walking or jogging at 60-80% of the heart rate (HR) reserve. The exercise intensity was determined using the Karvonen method target HR = [Exercise Intensity × (HRmax - resting HR)] + resting HR. The HR was recorded during each session using an HR monitor (Polar RS400sd; Madison Height, Michigan, USA). The control group was asked to maintain their regular physical activity level for 12 weeks.

Exercise training was conducted at the Kosin University Gospel Hospital U-Healthcare Center. All subjects were engaged in exercise training under the expert supervision of a director and were trained to immediately notify the director of any abnormal symptoms during the exercise training and to consult a doctor if needed. For both the EG and TM groups, exercise training was comprised of a 5 minute warm-up, a 40 minute main exercise, and a 5 minute cool-down. After a necessary 2 week initial adjustment period, the exercise training was conducted 3 times per week for 12 weeks. Subjects who did not perform more than 80% of the 12 week exercise program were excluded from this study.

Statistical Analysis All values are presented as the mean ± standard deviation (SD). We used the chi-square test for category type variables. The paired t-test was used to compare the baseline and data after the 12 week exercise intervention for each group. One-way ANOVA with repeated measures (group × time) was used to compare the data between groups. Bonferroni post-hoc analysis was performed to evaluate the differences among groups. Pearson's correlation was used to evaluate the relationship between variables. Statistical significance was set to p<0.05. For statistical analysis, SPSS 21.0 (SPSS, Chicago, IL, USA), a statistical program for Windows, was used.

Being tested
exergame, treadmill exercise
Keywords
Aerobic exercise, Exergame, cardiorespiratory fitness, endothelial function, epicardial fat
Medical subject headings
Cardiovascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • exergameBehavioural

    Exergame is 'exercise + game'.

  • treadmill exerciseBehavioural

    traditional aerobic exercise

Study groups in NCT04042896
Study groupRoleWhat they receive
exergame groupExperimentalThe exergame group performed exercise using the Exer Heart device (D\&J Humancare, Seoul, South Korea), which consisted of a running/jumping board and a screen connected to the board. The exercise program "Alchemist's Treasure", a running-based exergame, moves the avatar according to the user's motions and was used for the exercise session. "Alchemist's Treasure" is a game in which the user listens to stimulating music, runs with the avatar, avoiding obstacles, and wins items using the front, back, left, and right sensors on the exercise board. The subject can control the speed of the avatar movement by adjusting the walking or running speed on the board. This study did not enforce exercise intensity in order to allow patients to enjoy the exergame. Thus, during the training period, the patients exercised at a self-selected pace for 40 minutes per day.
Receives: Behavioral: exergame
treadmill groupActive comparatorThe treadmill group consisted of 40 minutes of walking or jogging at 60-80% of the heart rate (HR) reserve. The exercise intensity was determined using the Karvonen method target HR = [Exercise Intensity × (HRmax - resting HR)] + resting HR. The HR was recorded during each session using an HR monitor (Polar RS400sd; Madison Height, Michigan, USA). The control group was asked to maintain their regular physical activity level for 12 weeks.
Receives: Behavioral: treadmill exercise
control groupNo interventionThe control group was asked to maintain their regular physical activity level for 12 weeks.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of volume of maximal oxygen uptake

    maximal oxygen uptake refers to the ability of the circulatory and respiratory systems to supply oxygen to skeletal muscles during sustained physical activity.

    Measured: Change from Baseline maximal oxygen uptake at 3 months

Secondary outcomes (2)
  1. Change of percent of flow mediated dilation

    Flow-mediated dilation (FMD) refers to dilation (widening) of an artery when blood flow increases in that artery. The primary cause of FMD is release of nitric oxide by endothelial cells.

    To determine FMD, brachial artery dilation following a transient period of forearm ischemia is measured using ultrasound. Because the value of FMD can be compromised when improperly applied, attempts have been made to standardize the methodology for measuring FMD.

    Measured: Change from Baseline flow mediated dilation at 3 months

  2. Change of thickness of epicardial adipose tissue

    Epicardial adipose tissue (EAT) is a particular form of visceral fat deposited around the heart and found to be a metabolically active organ that generates various bioactive molecules, which might significantly affect cardiac function. Marked component differences have been observed in comparing EAT with subcutaneous fat, suggesting a depot specific impact of stored fatty acids on adipocyte function and metabolism.

    Measured: Change from Baseline epicardial adipose tissue at 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2019
  2. Study start1 Apr 2017
  3. Primary completion31 Dec 2017
  4. Study completion31 Mar 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
exergame group, treadmill group and control group
Masking
None (open label)
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04042896
Sponsor's protocol ID
EXERHEART
Status last verified
Jul 2019
First submitted
31 Jul 2019
Last updated
2 Aug 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Baranowski T, Abdelsamad D, Baranowski J, O'Connor TM, Thompson D, Barnett A, Cerin E, Chen TA. Impact of an active video game on healthy children's physical activity. Pediatrics. 2012 Mar;129(3):e636-42. doi: 10.1542/peds.2011-2050. Epub 2012 Feb 27.

    PubMed 22371457

Questions about this trial

What is this clinical trial studying?

A study testing exergame and treadmill exercise in people with Aerobic Exercise and Cardiorespiratory Fitness, run by Kyoung Im Cho at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of volume of maximal oxygen uptake (time frame: Change from Baseline maximal oxygen uptake at 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04042896, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in